Metsera rises as experimental weight-loss drug shows promise in small early-stage trial Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's ...

Novo Nordisk became only the eighth company to be suspended from the ABPI in its 40-year history for several transgressions, the most serious of which was a breach of Clause 2 of the code ...

the company notes that 90% of patients taking the drug are insured with a co-pay of between $0 and $25 per month. Novo Nordisk also said that it would be updating the price of the drug "so that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...